ACVC Partners

Founded in 2017 by Dr. Matthew Hill, Elegen is a biotechnology company specializing in microfluidic technology for the development of advanced DNA synthesizers. Its mission is to accelerate biomedical progress through innovative synthetic biology solutions.

EnCharge AI specializes in AI compute solutions, spanning from edge to cloud. The company focuses on delivering efficient and sustainable technology for AI computation, empowering businesses to utilize advanced AI models without constraints of power, space, or cost. Their products support diverse applications, facilitating enhanced performance and scalability in AI-driven initiatives.

Founded in 2016, Helm.ai develops advanced AI software for autonomous driving, ADAS, and robotics automation. Headquartered in Redwood City, CA, the company specializes in full-stack real-time AI solutions, including deep neural networks for highway and urban driving, end-to-end autonomous systems, and development tools powered by Deep Teaching™ and generative AI.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Founded in 2016, Helm.ai develops advanced AI software for autonomous driving, ADAS, and robotics automation. Headquartered in Redwood City, CA, the company specializes in full-stack real-time AI solutions, including deep neural networks for highway and urban driving, end-to-end autonomous systems, and development tools powered by Deep Teaching™ and generative AI.

Boston Materials designs and manufactures advanced composite materials, including carbon fiber pre-pregs enabled by its patented Z-axis Fiber technology, which uses vertically aligned carbon fibers to improve energy transfer. The company produces magnetically assembled carbon fiber pre-pregs and other specialty materials for semiconductors, aerospace platforms, and thermal management, delivering lightweight, high-performance solutions for electronics, aviation, electrified vehicles, and related industries. Its processes include roll-to-roll manufacturing with in-line quality control to support scalable production and consistent quality across applications.

Sepion Technologies is an advanced membrane company based in Emeryville, California, founded in 2015. It specializes in the development of highly-tunable nanoscale membranes designed for various industrial applications, particularly in the energy storage sector. The company focuses on manufacturing innovative lithium-metal batteries by integrating nanoscience, polymer chemistry, and cell engineering. Its proprietary composite membrane serves as a cost-effective alternative to traditional ceramic separators used in lithium batteries, allowing for large-area production. This technology enables battery manufacturers to enhance energy density in their products, thereby improving overall performance and efficiency in energy storage solutions.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Boston Materials designs and manufactures advanced composite materials, including carbon fiber pre-pregs enabled by its patented Z-axis Fiber technology, which uses vertically aligned carbon fibers to improve energy transfer. The company produces magnetically assembled carbon fiber pre-pregs and other specialty materials for semiconductors, aerospace platforms, and thermal management, delivering lightweight, high-performance solutions for electronics, aviation, electrified vehicles, and related industries. Its processes include roll-to-roll manufacturing with in-line quality control to support scalable production and consistent quality across applications.

DarwinAI Corp. is a Canadian company that specializes in artificial intelligence technology, particularly in the development of deep neural networks for enterprise applications. Founded in 2017 and based in Waterloo, the company offers GenSynth, a software platform designed for developers and data scientists to streamline the deep learning development process. GenSynth employs generative synthesis technology, allowing for the automatic creation of optimized, explainable AI models that meet specific performance criteria while ensuring transparency throughout the development stages. Additionally, DarwinAI has developed an AI-powered visual quality inspection system aimed at enhancing the PCBA manufacturing lifecycle. This system leverages specialized optics and advanced algorithms to detect defects in products, improving quality and consistency while reducing costs for manufacturers.

Medable operates a global decentralized trial platform that connects patients, sites, and clinical trial teams. It streamlines trial design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform ensures patient access, improves experience, and enhances outcomes while adhering to healthcare sector's strict compliance, interoperability, and privacy concerns.